title: Prostate cancer: Time for active surveillance of intermediate-risk disease?
authors.affiliation: Division of Surgery and Interventional Sciences, University College London, 4th Floor, 74 Huntley Street, London WC1E 6AU, UK. hashim.ahmed@ucl.ac.uk
authors.forename: Hashim U
authors.initials: HU
authors.lastname: Ahmed
mesh_terms: D000368:Aged; D003657:Decision Making; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000032:analysis / Q000097:blood*; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D020266:Radiotherapy, Conformal / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D015996:Survival Rate; D013997:Time Factors; D006113:United Kingdom; D057832:Watchful Waiting / Q000379:methods*
chemical_list: D017430:Prostate-Specific Antigen